Sep 09 2015 Relmada Therapeutics Announces Issuance of U.S. Patent Covering SECUREL™ - an Abuse-Deterrent, Extended-Release, Technology Platform for Opioids View
Aug 17 2015 Relmada Therapeutics Receives Health Canada Clearance to Commence Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist View
Aug 12 2015 Relmada Therapeutics Announces Launch of New Website and Corporate Communication Channels View
Aug 10 2015 Relmada Therapeutics Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market View
Jul 27 2015 Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone View
